Usama Bin Naeem

Dr. Usama Bin Naeem

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Bionatura
Verified
Journal Article
Open access
UNUsama Bin Naeem
Usama Bin Naeem
WIWaqas Iftikhar
Waqas Iftikhar
MRMussarat Rafiq
Mussarat Rafiq
MKMuhammad Babar Khawar
Muhammad Babar Khawar
Moringa Oleifera is an interesting plant used in Asian traditional medicine. In this study, in vitro antibacterial and cytotoxic evaluation of sequential extracts (aqueous, ethanol, and chloroform) of Moringa Oleifera was carried out. The antibacterial analysis was estimated with minimum inhibitory concentration (MIC) by micro dilution of Moringa Oleifera against common poultry pathogens Clostridium perfringens type A and Escherichia coli, while cytotoxic evaluation was estimated by the reduction in cell viability due to apoptosis or necrosis by metabolic events in the presence and absence of crude extracts or tested component. The aqueous extract shows the highest percentage yield (45/50gm) succeeded by ethanol extract (5.5gm/50gm) and chloroform extract (0.2gm/50gm). In our study, the zone of inhibition of sequential extracts of Moringa Oleifera against Haemophilus species are highest for chloroform (17mm), intermediate for ethanol (13mm), and lowest for aqueous extract (12.3mm). For chloroform extract the CSP was calculated at 10 different concentrations, 2000 µg/ml, 1000µg/ml, 500µg/ml, 250µg/ml, 125µg/ml, 62.5µg/ml, 31.25µg/ml, 15.63µg/ml, 7.81µg/ml and 3.91µg/ml .The results for cell survival percentage (CSP) in the present research are 26%, 46%, 58%, 55%, 60%, 63%, 62%, 59%, 68% and 82% respectively. The CSP results of chloroform extract indicated that it is toxic for cells at ≥1000µg/ml. At 1000µg/ml concentration CSP was 46% which is > 50% and therefore it is cytotoxic. At higher concentrations, chloroform is more cytotoxic than hexane because at > 1000µg/ml the cell survival percentage was recorded to be < 50%. For ethanol extract CSP was calculated at 10 concentrations, 6000µg/ml, 3000µg/ml, 1500µg/ml, 750µg/ml, 375µg/ml, 187.5µg/ml, 93.75µg/ml, 46.85µg/ml, 23.43µg/ml and 11.71µg/ml. The CSP values are 18%, 48%, 60%, 58%, 69%, 56%, 59%, 74%, 57% and 78% respectively which indicate that at concentrations ≥3000µg/ml the chloroform extract is toxic for cells. At a concentration less than 3000µg/ml, the CSP is more than 50%. So, as compared to hexane and chloroform, ethanol extract is less toxic at higher concentrations. Cytotoxicity of aqueous extract was calculated at 10 concentrations, 5000µg/ml, 2500µg/ml, 1250µg/ml, 625µg/ml, 312.5µg/ml, 156.25µg/ml, 78.125µg/ml, 39.06µg/ml, 19.53µg/ml and 9.76µg/ml. The CSP values are 8%, 18%, 42%, 56%, 54%, 59%, 55%, 62% 59% and 66% respectively. At a concentration ≥625µg/ml, the aqueous extract is toxic for cells. The CSP at 625µg/ml is 42%, hence toxic for cells. The cell survival percentage is more than 50% at a concentration > 625µg/ml, indicating that aqueous extract is more toxic to the cell than the rest of the three (Hexane, Chloroform, Ethanol extracts) at higher concentrations.

5 November 2025 in Pakistan Journal of Medical & Health Sciences
Verified
Journal Article
Open access
AGAyesha Ghazanfar
Ayesha Ghazanfar
MSMaham Shaukat
Maham Shaukat
ASAqeedat Shahzad
Aqeedat Shahzad
AKAreej Khalid
Areej Khalid
UNUsama Bin Naeem
Usama Bin Naeem
Background: Mild gynecological issues, including vaginal discharge, dysmenorrhea, pelvic pain, urinary symptoms, and irregularities in menstruation are very common in women, but the effect of such issues on the quality of life has not been given due consideration. This burden has to be understood to enhance clinical care and patient well-being. Objective: To evaluate how minor gynecological complications affect the quality of life of the patients who visit a tertiary care hospital. Methods: This was an observational study at this hospital, with 100 women between the ages of 18 and 55 years who presented with minor gynecological issues. Clinical assessment, gynecological assessment and investigations were conducted. The WHOQOL-BREF questionnaire was used to determine the quality of life in the physical, psychological, social and environmental domains. Data were processed with the help of SPSS 25, and the comparison of the mean QoL scores was conducted with the help of the various types of complaints and the period of the symptom occurrence in years. Results: The reason that most presented was the abnormal vaginal discharge (34 percent), dysmenorrhea (22 percent), pelvic discomfort (18 percent), urinary symptoms (14 percent), and the menstrual irregularities (12 percent). The women who experienced vaginal discharge and pelvic pain scored significantly lower on physical and psychological QoL. The number of symptoms was significantly correlated with impairment and those who reported more than 6 months had significantly lower QoL in all domains. Conclusion: Recommendation Small gynecological complications have a severe impact on the quality of life of women, in particular, in case of chronic or repeated symptoms. Raising early awareness, prompt treatment and extensive counseling of the patient will assist in lowering the total burden and enhancing wellbeing. Keywords: Minor gynecological complications, quality of life, vaginal discharge, dysmenorrhea, pelvic discomfort, WHOQOL-BREF, and the health of women.

27 April 2026 in Microbiology Research
Verified
Journal Article
Open access
PDF file
WAWaqas Ahmad
Waqas Ahmad
NRNaeem Rasool
Naeem Rasool
QAQurat ul Ain
Qurat ul Ain
UNUsama Bin Naeem
Usama Bin Naeem
MAMuhammad Azeem
Muhammad Azeem
MAMehmood Ahmad
Mehmood Ahmad
Trypanosoma evansi (T. evansi) infection poses a significant health threat to equines. This study was aimed to assess the prevalence, risk factors, hematobiochemical alterations, and oxidative stress-mediated genotoxicity associated with equine trypanosomiasis in the Rahim Yar Khan District. This cross-sectional study was conducted on 384 equines from October 2024 to September 2025. Blood samples were collected for thin blood film microscopy and PCR assay using RoTat 1.2 primers. Hematological indices were analyzed with an automated hematology analyzer; serum biochemical parameters were quantified via standard assays. Oxidative stress markers, including malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), and reduced glutathione (GSH), were also measured. Genotoxicity was evaluated using the alkaline comet assay. Statistical analyses included the chi-square test, logistic regression, and independent t-tests. T. evansi was detected in 5.99% of samples by microscopy and 10.16% by PCR, with no significant association with species, age, or sex. Infected equines exhibited significant reductions in hemoglobin (5.4 ± 0.6 vs. 10.8 ± 0.5 g/dL; p < 0.0001), total serum protein (2.1 ± 0.3 vs. 5.8 ± 0.2 g/dL; p < 0.0001), albumin, and globulin, alongside elevated hepatic enzymes, blood urea nitrogen, and creatinine (all p < 0.01). Oxidative stress was confirmed by increased MDA (p < 0.0001) and decreased CAT activity (p < 0.001). Genotoxicity was significantly higher in infected animals (genetic damage index; 1.12 ± 0.08 vs. 0.40 ± 0.01; p < 0.01). This study provides the first integrated assessment of molecular epidemiology and oxidative stress-mediated genotoxicity in equines in this region, suggesting the pathogenic impact of the infection and targeted diagnostics for disease management strategies.